1. Home
  2. PTGX vs CABO Comparison

PTGX vs CABO Comparison

Compare PTGX & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • CABO
  • Stock Information
  • Founded
  • PTGX 2006
  • CABO 1980
  • Country
  • PTGX United States
  • CABO United States
  • Employees
  • PTGX N/A
  • CABO N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • CABO Cable & Other Pay Television Services
  • Sector
  • PTGX Health Care
  • CABO Telecommunications
  • Exchange
  • PTGX Nasdaq
  • CABO Nasdaq
  • Market Cap
  • PTGX 3.3B
  • CABO 717.5M
  • IPO Year
  • PTGX 2016
  • CABO N/A
  • Fundamental
  • Price
  • PTGX $53.00
  • CABO $124.47
  • Analyst Decision
  • PTGX Strong Buy
  • CABO Hold
  • Analyst Count
  • PTGX 9
  • CABO 3
  • Target Price
  • PTGX $67.11
  • CABO $231.00
  • AVG Volume (30 Days)
  • PTGX 923.4K
  • CABO 210.9K
  • Earning Date
  • PTGX 08-05-2025
  • CABO 07-31-2025
  • Dividend Yield
  • PTGX N/A
  • CABO 7.09%
  • EPS Growth
  • PTGX N/A
  • CABO N/A
  • EPS
  • PTGX 0.86
  • CABO N/A
  • Revenue
  • PTGX $207,801,000.00
  • CABO $1,555,831,000.00
  • Revenue This Year
  • PTGX N/A
  • CABO N/A
  • Revenue Next Year
  • PTGX $53.09
  • CABO N/A
  • P/E Ratio
  • PTGX $61.48
  • CABO N/A
  • Revenue Growth
  • PTGX N/A
  • CABO N/A
  • 52 Week Low
  • PTGX $32.50
  • CABO $121.37
  • 52 Week High
  • PTGX $60.60
  • CABO $437.00
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 53.99
  • CABO 36.92
  • Support Level
  • PTGX $49.38
  • CABO $126.35
  • Resistance Level
  • PTGX $51.51
  • CABO $137.88
  • Average True Range (ATR)
  • PTGX 2.02
  • CABO 6.48
  • MACD
  • PTGX -0.39
  • CABO 1.54
  • Stochastic Oscillator
  • PTGX 46.09
  • CABO 11.85

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: